This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Universite Evry Val D'essone. Active years: 2015.
Company Filing History:
1 out of 5,383 
1 out of 1,853 
1 out of 1 
Years Active: 2015
Title: Sandrine Betuing: Innovator in Huntington's Disease Therapy
Introduction
Sandrine Betuing is a notable inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the treatment of Huntington's disease. Her innovative work has led to the development of a unique expression vector that holds promise for therapeutic applications.
Latest Patents
Sandrine Betuing holds a patent for an "Expression vector for cholesterol 24-hydrolase in therapy of Huntington's disease." This invention relates to a vector designed for use in the treatment of Huntington's disease, which comprises a cholesterol 24-hydroxylase encoding nucleic acid. This patent represents a crucial step forward in the quest for effective therapies for this debilitating condition. She has 1 patent to her name.
Career Highlights
Throughout her career, Sandrine has worked with esteemed institutions such as the National Institute of Health and Medical Research and Université Paris Descartes. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Jocelyne Caboche and Patrick Aubourg. Their collaborative efforts have further advanced the understanding and treatment of neurological diseases.
Conclusion
Sandrine Betuing's innovative contributions to the field of Huntington's disease therapy highlight her dedication to medical research and her role as a leading inventor. Her work continues to inspire advancements in therapeutic approaches for complex neurological conditions.